Clinical Trial Update: Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating NovoTTF-100A tumor treating fields in combination with temozolomide for newly diagnosed glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• NovoTTF-100A (Tumor Treating Fields therapy)
• Temozolomide (Temozolomide)

Snippet

Sponsor: NovoCure Ltd. | Conditions: Glioblastoma Multiforme | Phase 3 | Status: COMPLETED